Hien Liu

2.3k total citations
62 papers, 594 citations indexed

About

Hien Liu is a scholar working on Oncology, Hematology and Immunology. According to data from OpenAlex, Hien Liu has authored 62 papers receiving a total of 594 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 29 papers in Hematology and 17 papers in Immunology. Recurrent topics in Hien Liu's work include CAR-T cell therapy research (27 papers), Multiple Myeloma Research and Treatments (15 papers) and Hematopoietic Stem Cell Transplantation (14 papers). Hien Liu is often cited by papers focused on CAR-T cell therapy research (27 papers), Multiple Myeloma Research and Treatments (15 papers) and Hematopoietic Stem Cell Transplantation (14 papers). Hien Liu collaborates with scholars based in United States, China and Switzerland. Hien Liu's co-authors include Frederick L. Locke, Marco L. Davila, Farhad Khimani, Julio C. Chávez, Bijal Shah, Aleksandr Lazaryan, Michael D. Jain, Navneet S. Majhail, Taiga Nishihori and Gabriel Krivenko and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Hien Liu

55 papers receiving 592 citations

Peers

Countries citing papers authored by Hien Liu

Since Specialization

Citations

This map shows the geographic impact of Hien Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hien Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hien Liu more than expected).

Fields of papers citing papers by Hien Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hien Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hien Liu. The network helps show where Hien Liu may publish in the future.

Co-authorship network of co-authors of Hien Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Hien Liu. A scholar is included among the top collaborators of Hien Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hien Liu. Hien Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Enhanced CAR-T cell function and mitochondrial fitness from earlier unfractionated stem cell product in multiple myeloma 2025 ·Molecular Therapy ·Ciara L. Freeman, (unknown), Meghan Menges, (unknown), (unknown), Hien Liu, (unknown), Luís Delgado, (unknown), (unknown), (unknown), Omar Castañeda Puglianini, José L. Ochoa-Bayona, Doris K. Hansen, Melissa Alsina, Rachid Baz, Taiga Nishihori, Kenneth H. Shain, Frederick L. Locke	1
2	P-027 Real World Experience of Standard of Care Talquetamab in Patients with Relapsed and Refractory Multiple Myeloma 2024 ·Clinical Lymphoma Myeloma & Leukemia ·Ariel Grajales‐Cruz, (unknown), Doris K. Hansen, (unknown), (unknown), Brandon Blue, Hien Liu, José L. Ochoa-Bayona, Ciara L. Freeman, Frederick L. Locke, Taiga Nishihori, Kenneth H. Shain, Rachid Baz, Melissa Alsina	1
3	Effect of talquetamab on responses in patients with relapsed and refractory multiple myeloma with prior exposure to T-cell directed therapies. 2024 ·Journal of Clinical Oncology ·(unknown), Omar Castañeda Puglianini, Doris K. Hansen, (unknown), Brandon Blue, (unknown), Hien Liu, José L. Ochoa-Bayona, Ciara L. Freeman, Frederick L. Locke, Taiga Nishihori, Kenneth H. Shain, Rachid Baz, Melissa Alsina, Ariel Grajales‐Cruz	1
4	Paired Analysis from Patients with Myeloma Elucidates Favorable CAR-T Manufacture and Phenotype, Starting from Mobilized Pre-Transplant Apheresis Vs. Non-Mobilized Apheresis after Four Prior Lines 2023 ·Blood ·Ciara L. Freeman, (unknown), Meghan Menges, (unknown), Hien Liu, (unknown), (unknown), (unknown), (unknown), (unknown), José L. Ochoa-Bayona, Rachid Baz, Doris K. Hansen, Melissa Alsina, Kenneth H. Shain, Taiga Nishihori, (unknown), Frederick L. Locke	1
5	A Retrospective Study of Extracorporeal Photopheresis (ECP) in Treatment of Cutaneous T-Cell Lymphoma (CTCL) Evaluating Global, Skin and Blood Responses 2023 ·Blood ·(unknown), (unknown), (unknown), (unknown), Yumeng Zhang, L. Frank Glass, Kaaron Benson, Hien Liu, Lubomir Sokol	0
6	The Cell and Gene Therapy Consortium's Perspective on Harmonizing Data Collection for Patient Enrollment, Therapy Ordering and Scheduling, and Cell Collection 2023 ·Transplantation and Cellular Therapy ·(unknown), Linda Barnes, Clint Divine, Noelle V. Frey, Christian Fuchs, (unknown), (unknown), (unknown), Hien Liu, David Porter, (unknown), Sanjay Srivastava	2
7	Lack of defined apheresis collection criteria in publicly available CAR‐T cell clinical trial descriptions: Comprehensive review of over 600 studies 2022 ·Journal of Clinical Apheresis ·Suzanne R. Thibodeaux, Nicole A. Aqui, Yara A. Park, Jennifer Schneiderman, Leon Su, Jeffrey L. Winters, Abba C. Zubair, Joseph E. Schwartz, Hien Liu	10
8	Considerations for immune effector cell therapy collections: a white paper from the American Society for Apheresis 2022 ·Cytotherapy ·Hien Liu, Leon Su, Jeffrey L. Winters, Suzanne R. Thibodeaux, Yara A. Park, Yanyun Wu, Joseph E. Schwartz, Abba C. Zubair, Jennifer Schneiderman, Gaurav K. Gupta, (unknown), Nicole A. Aqui	5
9	Factors Affecting Lymphocyte Collection Efficiency and Manufactured Product Specification during Leukapheresis for Diffuse Large B Cell Lymphoma Patients Treated with Commercial Tisagenlecleucel 2020 ·Blood ·Ariel Perez Perez, Christina A. Bachmeier, (unknown), (unknown), Aleksandr Lazaryan, Julio C. Chávez, Claudio Anasetti, Bijal Shah, Farhad Khimani, Taiga Nishihori, Marco L. Davila, Frederick L. Locke, Michael D. Jain, Hien Liu	3
10	High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphoma 2020 ·Blood Advances ·Erin Dean, Rahul Mhaskar, Hong Lü, (unknown), Gabriel Krivenko, Aleksandr Lazaryan, Christina A. Bachmeier, Julio C. Chávez, Taiga Nishihori, Marco L. Davila, Farhad Khimani, Hien Liu, Javier Pinilla‐Ibarz, Bijal Shah, Michael D. Jain, Yoganand Balagurunathan, Frederick L. Locke	146
11	Incidence and Management of Effusions Before and After CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy in Large B Cell Lymphoma 2020 ·Transplantation and Cellular Therapy ·Abu‐Sayeef Mirza, Ambuj Kumar, Hamza Hashmi, (unknown), (unknown), (unknown), Rawan Faramand, Kayla Reid, Christina A. Bachmeier, Julio C. Chávez, Bijal Shah, Javier Pinilla‐Ibarz, Farhad Khimani, Aleksandr Lazaryan, Hien Liu, Marco L. Davila, Taiga Nishihori, Frederick L. Locke, Michael D. Jain	7
12	Influence of major histocompatibility complex class I chain-related gene A polymorphisms on cytomegalovirus disease after allogeneic hematopoietic cell transplantation 2019 ·Hematology/Oncology and Stem Cell Therapy ·Sagar S. Patel, Lisa Rybicki, (unknown), Dawn Thomas, Hien Liu, Robert M. Dean, Deepa Jagadeesh, Brian T. Hill, Brad Pohlman, Brian J. Bolwell, Rabi Hanna, Betty K. Hamilton, Matt Kalaycio, Aaron T. Gerds, Eric Cober, Sherif B. Mossad, Aiwen Zhang, Navneet S. Majhail, Medhat Askar, Ronald Sobecks	6
13	Radiation Therapy as a Bridging Strategy for CAR T Cell Therapy With Axicabtagene Ciloleucel in Diffuse Large B-Cell Lymphoma 2019 ·International Journal of Radiation OncologyBiologyPhysics ·Austin J. Sim, Michael D. Jain, Nicholas Figura, Julio C. Chávez, Bijal Shah, Farhad Khimani, Aleksandr Lazaryan, Gabriel Krivenko, Marco L. Davila, Hien Liu, Aaron D. Falchook, Saurabh Dahiya, Aaron P. Rapoport, Sungjune Kim, Frederick L. Locke, Timothy J. Robinson	106
14	Effect of bone marrow CD34+cells and T-cell subsets on clinical outcomes after myeloablative allogeneic hematopoietic cell transplantation 2018 ·Bone Marrow Transplantation ·Sagar S. Patel, Lisa Rybicki, (unknown), (unknown), Brian J. Bolwell, Robert M. Dean, Priscilla Figueroa, Rabi Hanna, Hien Liu, Aaron T. Gerds, Brian T. Hill, Deepa Jagadeesh, Matt Kalaycio, Brad Pohlman, Kristin Ricci, Ronald Sobecks, (unknown), Betty K. Hamilton, Navneet S. Majhail	11
15	Hematopoietic Progenitor Cell Mobilization for Autologous Stem Cell Transplantation in Multiple Myeloma in Contemporary Era 2018 ·Clinical Lymphoma Myeloma & Leukemia ·Satyam Arora, Navneet S. Majhail, Hien Liu	31
16	Prognostic Factors for Mortality among Day +100 Survivors after Allogeneic Hematopoietic Cell Transplantation 2018 ·Biology of Blood and Marrow Transplantation ·Sagar S. Patel, Lisa Rybicki, (unknown), Brian J. Bolwell, Robert M. Dean, Hien Liu, Aaron T. Gerds, Rabi Hanna, Brian T. Hill, Deepa Jagadeesh, Matt Kalaycio, Brad Pohlman, Ronald Sobecks, Navneet S. Majhail, Betty K. Hamilton	10
17	Neutropenic fever during peripheral blood progenitor cell mobilization is associated with decreased CD34+ cell collection and increased apheresis collection days 2017 ·Journal of Clinical Apheresis ·Jack Khouri, Lisa Rybicki, Navneet S. Majhail, Matt Kalaycio, Edward A. Copelan, Brad Pohlman, Brian T. Hill, Robert M. Dean, Aleksandr Lazaryan, Betty K. Hamilton, Steven Andrèsen, Ronald Sobecks, Brian J. Bolwell, Hien Liu	6
18	Conditional Long-Term Survival Among Diffuse Large B-Cell Lymphoma (DLBCL) Patients Treated with Autologous Hematopoietic Cell Transplantation (AHCT) 2017 ·Blood ·(unknown), Lisa Rybicki, Brian J. Bolwell, Mohamed A. Kharfan‐Dabaja, Robert M. Dean, Betty K. Hamilton, Rabi Hanna, Deepa Jagadeesh, Matt Kalaycio, Hien Liu, Brad Pohlman, Ronald Sobecks, Brian T. Hill, Navneet S. Majhail	1
19	Association of Socioeconomic Status with Outcomes of Autologous Hematopoietic Cell Transplantation for Multiple Myeloma 2016 ·Biology of Blood and Marrow Transplantation ·Sanghee Hong, Lisa Rybicki, (unknown), Brian J. Bolwell, Robert M. Dean, Aaron T. Gerds, Betty K. Hamilton, Brian T. Hill, Deepa Jagadeesh, Matt Kalaycio, Hien Liu, Brad Pohlman, Ronald Sobecks, Navneet S. Majhail	9
20	Long-term survival after high-dose chemotherapy with autologous hematopoietic cell transplantation in metastatic breast cancer 2015 ·Hematology/Oncology and Stem Cell Therapy ·Betty K. Hamilton, Lisa Rybicki, (unknown), Steven Andrèsen, Matt Kalaycio, Ronald Sobecks, Brad Pohlman, Rabi Hanna, Robert M. Dean, Hien Liu, Brian T. Hill, Brian J. Bolwell, Edward A. Copelan	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact